The Chris Voss Show Podcast – Saving Lives: Joseph Nounou’s Revolutionary ResPen for Overdoses

Saving Lives: Joseph Nounou's Revolutionary ResPen for Overdoses Aurospharma.com About the Guest(s): Joseph Nounou, MD, MBA, is an innovative anesthesiologist passionate about expanding the accessibility of life-saving medical interventions. From a young age, Joseph was inspired to pursue a career in medicine, culminating in his graduation from medical school and residency as an anesthesiologist. In addition to his medical expertise, he pursued an MBA from the Haslam School of Business at the University of Tennessee to understand the business elements of getting medical products to market. With a commitment to empowering individuals, Joseph developed the ResPen, an affordable and accessible way to administer life-saving medication to victims of drug overdoses. Episode Summary: In this engaging episode of The Chris Voss Show, host Chris Voss is joined by visionary anesthesiologist, Joseph Nounou, MD, MBA. As they embark on a thought-provoking conversation, the spotlight is on Joseph's revolutionary creation, the ResPen, designed to rescue individuals from life-threatening situations like drug overdoses. With over 107,000 overdose fatalities a year in the US alone, Joseph's groundbreaking device is poised to change the landscape of emergency medical intervention. The discussion explores the intricate balance of medicine and business behind the invention, Joseph's personal journey, and his unwavering commitment to saving lives. During the episode, Joseph and Chris delve into the growing opioid and fentanyl crisis that underscores the need for the ResPen. By focusing on creating a fast-acting solution that even those without medical training can use, Joseph aims to significantly reduce the death toll from overdoses. The conversation also highlights the ResPen's application for cardiac arrest situations, stressing the critical few minutes during which a life can be saved. Beyond discussing this life-saving device, Joseph offers insights on how partnerships and investments can accelerate their mission, and how listeners can get involved. Key Takeaways: Joseph Nunu, MD, MBA, is behind the development of the ResPen, a life-saving device aimed at reducing fatalities from drug overdoses and cardiac arrests. The ResPen is an innovative solution that allows non-medical personnel to administer crucial medication in emergency situations. Drug overdoses claim over 107,000 lives annually in the US, highlighting the urgent need for accessible emergency interventions like the ResPen. Joseph emphasizes the potential of partnerships and investments to bring the ResPen to market faster, urging listeners to get involved in the mission. The FDA's fast-track designation could expedite the ResPen's journey to the public, aligning with the urgency of the opioid crisis. Notable Quotes: "The worst person in the world is probably someone who's evil, so don't be evil." – Chris Voss "It turns out that 350,000 people die outside of the hospital every year from sudden cardiac arrest." – Joseph Nunu "In that period of time, the brain will die. The brain only lives for about five to eight minutes without oxygen." – Joseph Nunu "It's a whole jumbo jet full of people every single day and nobody really pays that much mind because it's just the baseline." – Joseph Nunu "We have a lifesaving medication that really could use some political backing and really could use a quality partner in the pharmaceutical industry." – Joseph Nunu